Is it equivalent?: a comparison of the clinical activity of Lipodox compared to Doxil in the treatment of recurrent ovarian cancer

Smith, Judith

174 - Poster Session A
Is it equivalent?: a comparison of the clinical activity of Lipodox compared to Doxil in the treatment of recurrent ovarian cancer

Saturday, March 22, 2014: 8:05 PM

West Exhibit Hall (Tampa Convention Center)

J. A. Smith¹, A. B. Costales², M. Jaffari¹, D. Urbauer¹, M. Frumovitz¹, C. K. Kutac¹, H. Tran¹ and R. L. Coleman¹
¹The University of Texas MD Anderson Cancer Center, Houston, TX, ²The University of Texas Medical School at Houston, Houston, TX

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

174 - Poster Session A
Is it equivalent?: a comparison of the clinical activity of Lipodox compared to Doxil in the treatment of recurrent ovarian cancer

174 - Poster Session A Is it equivalent?: a comparison of the clinical activity of Lipodox compared to Doxil in the treatment of recurrent ovarian cancer

174 - Poster Session A
Is it equivalent?: a comparison of the clinical activity of Lipodox compared to Doxil in the treatment of recurrent ovarian cancer